Management of Chronic Obstructive Pulmonary Disease in Switzerland
Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort COPD-Management: Eine Klinisch-epidemiologische Verlaufsbeobachtung in Hausarztpraxen
This study looks at how to better manage and treat people with COPD in Switzerland by checking their lung health and smoking history.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 265 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | Cantonal Hosptal, Baselland Academic / other |
| Locations | 1 site (Liestal, Baselland) |
| Trial ID | NCT02065921 on ClinicalTrials.gov |
What this trial studies
This observational cohort focuses on individuals with Chronic Obstructive Pulmonary Disease (COPD) to improve management and treatment strategies. It aims to systematically diagnose and stratify patients to enhance early detection and prevent disease progression. The study will involve participants who meet specific criteria related to lung function and smoking history, allowing for a better understanding of COPD management in Switzerland.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals over 40 years old with a history of smoking and diagnosed with COPD characterized by specific lung function criteria.
Not a fit: Patients under 40 years old or those with a Tiffenau index greater than 70 may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for COPD, potentially reducing exacerbations and enhancing patient quality of life.
How similar studies have performed: Other studies have shown success in managing COPD through systematic approaches, indicating that this methodology is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Tiffenau (FEV17FVC) \< 70 without reversibility (Increase in FEV1 after inhalation of a bronchodilator \<200 ml and \<12%). * Age: \> 40 years * Both genders * Smokers or ex-smokers of at least 20 pack years. * Informed consent. Exclusion Criteria: * \< 40 Years * Tiffenau (FEV17FVC) \> 70
Where this trial is running
Liestal, Baselland
- Cantonal Hospital Baselland, Internal medicine University clinic — Liestal, Baselland, Switzerland (Recruiting)
Study contacts
- Study coordinator: Jörg D Leuppi, MD, PhD,Prof.
- Email: joerg.leuppi@ksbl.ch
- Phone: 061 925 2180
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.